Literature DB >> 27535123

Early blood pressure alterations are associated with pro-inflammatory markers in type 1 diabetes mellitus.

I Mateo-Gavira1, F J Vílchez-López1, M V García-Palacios2, F Carral-San Laureano3, F M Visiedo-García4, M Aguilar-Diosdado5.   

Abstract

The aim of this study was to evaluate the relationship between early blood pressure (BP) changes (detected using ambulatory BP monitoring; ABPM) with different markers of inflammation and endothelial dysfunction in patients with type 1 diabetes mellitus (T1DM). The study design was observational cross-sectional in 85 T1DM patients, clinically normotensive and with normo-albuminuria. We analyzed the relationships between ABPM-measured BP alterations over 24 h with the inflammatory cytokines (interleukin-6 (IL-6), tumor necrosis factor-α and vascular endothelial growth factor (VEGF)) and the markers of endothelial damage (vascular adhesion molecule, intercellular adhesion molecule and plasminogen activator inhibitor-1 (PAI)). Despite being recorded as normotensive, 27 (31.8%) subjects presented with an average of pathological BP. VEGF levels were significantly elevated in the patients with an altered mean diurnal values compared with normotensives (112.33 (72.87-213.53) pg ml-1 vs 71.03 (37.71-107.92) pg ml-1; P=0.007). Further, VEGF levels correlated significantly with the parameters of diurnal BP and of 24 h values. IL-6 concentration was a risk factor in the patients with hypertension (OR=1.406; P=0.027). There were no modifications in the levels of markers of endothelial damage. Summarizing, there is an increase in pro-inflammatory cytokines, but not the endothelial adhesion molecules, in early stages of arterial hypertension in patients with T1DM.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27535123     DOI: 10.1038/jhh.2016.56

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  40 in total

1.  Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Thomas Pickering; Roland Asmar; Martin Myers; Gianfranco Parati; Jan Staessen; Thomas Mengden; Yutaka Imai; Bernard Waeber; Paolo Palatini; William Gerin
Journal:  Blood Press Monit       Date:  2002-02       Impact factor: 1.444

2.  Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults.

Authors:  Jerome L Abramson; Cheryl Lewis; Nancy V Murrah; Grant T Anderson; Viola Vaccarino
Journal:  Am J Cardiol       Date:  2006-07-07       Impact factor: 2.778

3.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

Review 4.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  The control of hypertension in persons with diabetes: a public health approach.

Authors:  D Bild; S M Teutsch
Journal:  Public Health Rep       Date:  1987 Sep-Oct       Impact factor: 2.792

6.  Plasma levels of ICAM-1 and circulating endothelial cells are elevated in unstable types 1 and 2 diabetes.

Authors:  M El Amine; S Sohawon; L Lagneau; L Langneau; N Gaham; S Noordally
Journal:  Endocr Regul       Date:  2010-01

7.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome.

Authors:  Joji Ishikawa; Satoshi Hoshide; Kazuo Eguchi; Shizukiyo Ishikawa; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Hypertens       Date:  2008-06       Impact factor: 4.844

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

10.  Nitric oxide is a mediator of antiproliferative effects induced by proinflammatory cytokines on pancreatic beta cells.

Authors:  Laura Quintana-Lopez; Manuel Blandino-Rosano; Gonzalo Perez-Arana; Alberto Cebada-Aleu; Alfonso Lechuga-Sancho; Manuel Aguilar-Diosdado; Carmen Segundo
Journal:  Mediators Inflamm       Date:  2013-06-12       Impact factor: 4.711

View more
  2 in total

1.  Blood Pressure Monitoring and Perinatal Outcomes in Normotensive Women with Gestational Diabetes Mellitus.

Authors:  Almudena Lara-Barea; Begoña Sánchez-Lechuga; Álvaro Vidal-Suárez; Ana I Arroba; Fernando Bugatto; Cristina López-Tinoco
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241

Review 2.  IL-1β Implications in Type 1 Diabetes Mellitus Progression: Systematic Review and Meta-Analysis.

Authors:  Fátima Cano-Cano; Laura Gómez-Jaramillo; Pablo Ramos-García; Ana I Arroba; Manuel Aguilar-Diosdado
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.